An official website of the United States government
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Edoxaban (Lixiana) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.
| Drug | Edoxaban (Lixiana) |
|---|---|
| Indication | Prevention of stroke and systemic embolic events in patients with atrial fibrillation in whom anticoagulation is appropriate |
| Reimbursement Request | As per indication |
| Dosage Form (s) | Tablet 15 mg, 30 mg, and 60 mg |
| NOC Date | November 4, 2016 |
| Manufacturer | Servier Canada, Inc. |
Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
Your browsing activity is empty.
Activity recording is turned off.
See more...
